ADC Therapeutics SA Return on Investment 2019-2023 | ADCT
Current and historical return on investment (ROI) values for ADC Therapeutics SA (ADCT) over the last 10 years.
| ADC Therapeutics SA ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2023-03-31 |
$-0.14B |
$0.14B |
-73.37% |
| 2022-12-31 |
$-0.12B |
$0.19B |
-56.29% |
| 2022-09-30 |
$-0.18B |
$0.20B |
-71.50% |
| 2022-06-30 |
$-0.23B |
$0.21B |
-83.11% |
| 2022-03-31 |
$-0.23B |
$0.27B |
-72.64% |
| 2021-12-31 |
$-0.26B |
$0.29B |
-75.67% |
| 2021-09-30 |
$-0.28B |
$0.33B |
-72.09% |
| 2021-06-30 |
$-0.27B |
$0.38B |
-64.14% |
| 2021-03-31 |
$-0.25B |
$0.39B |
-59.71% |
| 2020-12-31 |
$-0.22B |
$0.44B |
-69.41% |
| 2020-06-30 |
$-0.12B |
$0.34B |
-145.24% |
| 2020-03-31 |
$-0.10B |
|
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.192B |
$0.210B |
|
ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.
|
